NEO - CIK 0001077183
NEOGENOMICS INC (NEO) reported revenue of $727.33M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $727.33M | +10.1% |
| FY 2024 | $660.57M | +11.6% |
| FY 2023 | $591.64M | +16.1% |
| FY 2022 | $509.73M | +5.2% |
| FY 2021 | $484.33M | +9.0% |
| FY 2020 | $444.45M | +8.7% |
| FY 2019 | $408.83M | +47.7% |
| FY 2018 | $276.74M | +15.2% |
| FY 2017 |
NEOGENOMICS INC (NEO) reported revenue of $727.33M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2016 and fiscal 2025, NEOGENOMICS INC's revenue grew from $231.81M to $727.33M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $240.25M |
| +3.6% |
| FY 2016 | $231.81M | - |